Figure 10.

Gene-drug network and molecular docking. (A) The potential gene-drug networks target TIGIT. (B) The 3D structure of the TIGIT protein. (C) The 2D structure of Selumetinib. (D) The 3D structure of Selumetinib. (E) The molecular docking between Selumetinib and TIGIT showed Selumetinib could enter into the active pocket of TIGIT protein. (F) The 2D structure of PD0325901. (G) The 3D structure of PD0325901. (H) The molecular docking between PD0325901and TIGIT showed PD0325901could enter into the active pocket of TIGIT protein.